Literature DB >> 30952681

Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders.

Sara Mariotto1, Sergio Ferrari2, Matteo Gastaldi3, Diego Franciotta3, Elia Sechi4, Ruggero Capra5, Chiara Mancinelli5, Kathrin Schanda6, Daniela Alberti2, Riccardo Orlandi2, Roberto Bombardi7, Luigi Zuliani8, Marco Zoccarato9, Maria Donata Benedetti2, Raffaella Tanel10, Francesca Calabria11, Francesca Rossi12, Antonino Pavone13, Luisa Grazian14, GianPietro Sechi15, Lucia Batzu4, Noemi Murdeu4, Francesco Janes16, Vincenza Fetoni17, Daniela Fulitano18, Gianola Stenta19, Lisa Federle19, Gaetano Cantalupo20, Markus Reindl6, Salvatore Monaco2, Alberto Gajofatto2.   

Abstract

Entities:  

Keywords:  MOG; NMOSD; myelitis; neurofilament light chain; optic neuritis

Year:  2019        PMID： 30952681     DOI： 10.1136/jnnp-2018-320287

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Upregulated Retinal Neurofilament Expression in Experimental Optic Neuritis.

Authors:  Robert Weissert; Therése Hugosson; Axel Petzold
Journal:  Neuroophthalmology       Date:  2022-01-26

Review 2.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.

Authors:  Elia Sechi; Laura Cacciaguerra; John J Chen; Sara Mariotto; Giulia Fadda; Alessandro Dinoto; A Sebastian Lopez-Chiriboga; Sean J Pittock; Eoin P Flanagan
Journal:  Front Neurol       Date:  2022-06-17       Impact factor: 4.086

3.  Anti-MOG-associated demyelinating disorders: two sides of the same coin.

Authors:  Giorgia Teresa Maniscalco; Lia Allegorico; Gennaro Alfieri; Massimo Napolitano; Angelo Ranieri; Rosaria Renna; Giovanna Servillo; Marianna Pezzella; Elisa Capone; Lidia Altomare; Michele Spiniello; Sergio Ferrari; Valentino Manzo; Sara Mariotto
Journal:  Neurol Sci       Date:  2020-11-14       Impact factor: 3.307

4.  Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS.

Authors:  Sinah Engel; Falk Steffen; Timo Uphaus; Peter Scholz-Kreisel; Frauke Zipp; Stefan Bittner; Felix Luessi
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-02-04

5.  CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.

Authors:  Mette Scheller Nissen; Matias Ryding; Anna Christine Nilsson; Jonna Skov Madsen; Dorte Aalund Olsen; Ulrich Halekoh; Magnus Lydolph; Zsolt Illes; Morten Blaabjerg
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

Review 6.  Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.

Authors:  Alessandro Dinoto; Elia Sechi; Eoin P Flanagan; Sergio Ferrari; Paolo Solla; Sara Mariotto; John J Chen
Journal:  Front Neurol       Date:  2022-03-23       Impact factor: 4.003

7.  Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder.

Authors:  Lingyao Kong; Yanlin Lang; Xiaofei Wang; Jiancheng Wang; Hongxi Chen; Ziyan Shi; Hongyu Zhou
Journal:  Front Neurol       Date:  2022-09-16       Impact factor: 4.086

8.  Mortality of neuromyelitis optica spectrum disorders in a Chinese population.

Authors:  Qin Du; Ziyan Shi; Hongxi Chen; Ying Zhang; Jiancheng Wang; Yuhan Qiu; Zhengyang Zhao; Qin Zhang; Hongyu Zhou
Journal:  Ann Clin Transl Neurol       Date:  2021-06-13       Impact factor: 4.511

9.  Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Hyunjin Kim; Eun-Jae Lee; Seungmi Kim; Lyn-Kyung Choi; Keonwoo Kim; Hye Weon Kim; Kwang-Kuk Kim; Young-Min Lim
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.